GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 32 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,110,000 | +263.9% | 232,172 | +163.1% | 0.01% | +50.0% |
| Q1 2020 | $305,000 | -41.9% | 88,243 | -2.8% | 0.01% | -38.5% |
| Q4 2019 | $525,000 | +51.3% | 90,748 | +25.0% | 0.01% | +62.5% |
| Q3 2019 | $347,000 | -22.5% | 72,595 | +19.1% | 0.01% | -27.3% |
| Q2 2019 | $448,000 | +2.1% | 60,948 | +13.4% | 0.01% | -15.4% |
| Q1 2019 | $439,000 | +57.3% | 53,749 | +31.6% | 0.01% | +18.2% |
| Q4 2018 | $279,000 | -42.7% | 40,844 | +13.9% | 0.01% | -26.7% |
| Q3 2018 | $487,000 | – | 35,846 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 965,000 | $3,339,000 | 3.36% |
| BVF INC/IL | 1,832,484 | $6,340,000 | 0.59% |
| P.A.W. CAPITAL CORP | 100,000 | $346,000 | 0.47% |
| Voss Capital, LLC | 159,454 | $319,000 | 0.43% |
| 683 Capital Management, LLC | 1,563,640 | $5,412,000 | 0.32% |
| Vivo Capital, LLC | 860,103 | $2,976,000 | 0.27% |
| Rock Creek Group, LP | 94,454 | $327,000 | 0.18% |
| Nantahala Capital Management | 1,303,652 | $4,511,000 | 0.17% |
| Phoenix Holdings Ltd. | 75,383 | $253,000 | 0.01% |
| ARK Investment Management | 88,243 | $305,000 | 0.01% |